Belite Bio, Inc (BLTE) NASDAQ
153.52
-2.02(-1.30%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
153.52
-2.02(-1.30%)
Currency In USD
| Market Cap | 5.36B |
| Enterprise Value | 5.01B |
| P/E Ratio | -66.34 |
| PEG Ratio | 1.19 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.68 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -68.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.1 |
| Return On Equity | -0.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -84.21M |
| Net Income | -77.61M |
| Diluted EPS | -2.31 |
| Total Cash | 492.42M |
| Total Cash/Share | 14.68 |
| Total Debt | 429,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 50.02 |
| Book Value Per Share | 22.97 |
| 52-Week Change | 152.13 |
| 52-Week High | 200 |
| 52-Week Low | 56.1 |
| Moving Average 50 Days | 163.33 |
| Moving Average 200 Days | 128.43 |
| Average Volume | 153,210 |
| Shares Outstanding | 39.97M |
| % Held by Institutions | 21.64 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |